Table 3.
Age (Weeks) | Sex | CF1-CD | CF1-HCD | DF1-CD | DF1-HCD |
---|---|---|---|---|---|
Adiponectin (ng/ml) | |||||
5 | Male | 12.8 ± 1.2 | 12.5 ± 1.3 | 12.4 ± 1.5 | 12.1 ± 1.1 |
Female | 17.9 ± 1.5*** | 16.9 ± 1.6*** | 17.0 ± 1.6*** | 16.8 ± 1.8*** | |
10 | Male | 13.2 ± 0.9 | 13 ± 1.2 | 12.0 ± 1.3* | 11.4 ± 1.2*,** |
Female | 17.6 ± 1.4*** | 16.5 ± 1.5*** | 16.7 ± 1.5 | 16.2 ± 1.7*** | |
15 | Male | 13.6 ± 1.4 | 13.1 ± 1.2 | 12.0 ± 1.4 | 11.2 ± 1.1*,** |
Female | 17.1 ± 1.5*** | 16.4 ± 1.2*** | 16.5 ± 1.6*** | 16.3 ± 1.5*** | |
20 | Male | 14 ± 1.1 | 12.6 ± 1.32* | 11.8 ± 1.2* | 9.8 ± 1*,** |
Female | 16.8 ± 1.6*** | 16.5 ± 1.5*** | 16.1 ± 2*** | 15.6 ± 2*** | |
25 | Male | 14.2 ± 1.3 | 12.4 ± 1.3* | 10.5 ± 1.4*,** | 9.3 ± 1.2*,** |
Female | 16.7 ± 2*** | 16.6 ± 2*** | 15.6 ± 1.8*** | 14.9 ± 2*,** | |
30 | Male | 14.8 ± 1.2 | 12.5 ± 1.2* | 10.0 ± 1.3*,** | 9.2 ± 1.1*,** |
Female | 16.6 ± 1.9*** | 16.4 ± 1.9*** | 15.4 ± 2*** | 14.2 ± 1.9*,**,*** | |
Leptin (ng/ml) | |||||
5 | Male | 0.54 ± 0.08 | 0.56 ± 0.07 | 0.62 ± 0.11* | 0.62 ± 0.1* |
Female | 1.6 ± 0.1*** | 1.64 ± 0.12*** | 1.71 ± 0.08***,** | 1.68 ± 0.11** | |
10 | Male | 0.3 ± 0.09 | 0.44 ± 0.09* | 0.38 ± 0.12* | 0.46 ± 0.1* |
Female | 1.1 ± 0.09*** | 1.18 ± 0.14*** | 1.3 ± 0.07*,**,*** | 1.43 ± 0.12*,**,*** | |
15 | Male | 0.26 ± 0.08 | 0.43 ± 0.11* | 0.34 ± 0.09*,** | 0.45 ± 0.14* |
Female | 0.94 ± 0.08*** | 0.96 ± 0.1*** | 1.04 ± 0.11*** | 1.22 ± 0.08*,**,*** | |
20 | Male | 0.24 ± 0.11 | 0.41 ± 0.09* | 0.330.08*,** | 0.44 ± 0.12* |
Female | 0.81 ± 0.11*** | 0.9 ± 0.06*** | 0.95 ± 0.09*,*** | 1.3 ± 0.11*,**,*** | |
25 | Male | 0.22 ± 0.09 | 0.4 ± 0.11* | 0.31 ± 0.1*,** | 0.45 ± 0.14* |
Female | 0.84 ± 0.12*** | 0.91 ± 0.14*** | 0.97 ± 0.12*,*** | 1.34 ± 0.1*,**,*** | |
30 | Male | 0.19 ± 0.09 | 0.41 ± 0.11* | 0.3 ± 0.05*,** | 0.42 ± 0.15* |
Female | 0.9 ± 0.1*** | 0.95 ± 0.1*** | 0.97 ± 0.15*** | 1.36 ± 0.12*,**,*** | |
TNF-α (pg/ml) | |||||
5 | Male | 17 ± 2.1 | 23 ± 2.1* | 26 ± 2.4*,** | 29 ± 2.3*,** |
Female | 23 ± 3*** | 24 ± 2.5 | 24 ± 2.7 | 26 ± 3*,*** | |
10 | Male | 19 ± 2.3 | 22 ± 2.4* | 37 ± 2.3*,** | 46 ± 4*,** |
Female | 25 ± 3*** | 26 ± 2.6*** | 31 ± 3.4*,**,*** | 29 ± 5*,**,*** | |
15 | Male | 19 ± 2 | 23 ± 2* | 42 ± 2.6*,** | 55 ± 5.3*,** |
Female | 27 ± 4*** | 31 ± 3*,*** | 33 ± 3.1*,*** | 34 ± 5*,*** | |
20 | Male | 20 ± 2.4 | 25 ± 2.4* | 52 ± 2*,** | 61 ± 6*,** |
Female | 29 ± 3*** | 33 ± 2.5*,*** | 32 ± 3*** | 36 ± 5*,*** | |
25 | Male | 21 ± 2.1 | 27 ± 2.1* | 60 ± 2.3*,** | 66 ± 7*,** |
Female | 30 ± 2*** | 34 ± 3*,*** | 33 ± 4*** | 41 ± 6*,**,*** | |
30 | Male | 22 ± 1.8 | 31 ± 2.2* | 71 ± 2.1*,** | 74 ± 7.8*,** |
Female | 32 ± 3*** | 35 ± 3*** | 35 ± 3.8*** | 44 ± 7*,**,*** |
Data are presented as mean ± SD (n = 10)
Abbreviations denote: CF1-CD; F1 offspring of control mothers under control diet, CF1-HCD; F1 offspring of control mothers under HCD, DF1-CD; F1 offspring of diabetic mothers under control diet, and DF1-HCD; F1 offspring of diabetic mothers under HCD
*Significant different from CF1-CD by ANOVA (p < 0.05)
**Significant different from CF-HCD by ANOVA (p < 0.05)
***Significant different from male at each age by t-test (p < 0.05)